Bionano Genomics, Inc. (BNGO)
1.48
-0.09
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
1.49
+0.01
(+0.68%)
Pre-Market: 20:00
Bionano Genomics Gross Profit Margin (Quarterly) : 52.80% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.80% |
| March 31, 2026 | 48.63% |
| December 31, 2025 | 42.75% |
| September 30, 2025 | 45.74% |
| June 30, 2025 | 51.64% |
| March 31, 2025 | 45.50% |
| December 31, 2024 | 41.86% |
| September 30, 2024 | -139.1% |
| June 30, 2024 | 33.26% |
| March 31, 2024 | 32.20% |
| December 31, 2023 | 22.74% |
| September 30, 2023 | 29.50% |
| June 30, 2023 | 26.65% |
| March 31, 2023 | 27.92% |
| December 31, 2022 | 21.97% |
| September 30, 2022 | 25.05% |
| June 30, 2022 | 22.05% |
| March 31, 2022 | 15.12% |
| December 31, 2021 | 3.79% |
| Date | Value |
|---|---|
| September 30, 2021 | 24.79% |
| June 30, 2021 | 37.32% |
| March 31, 2021 | 32.92% |
| December 31, 2020 | 15.37% |
| September 30, 2020 | 19.03% |
| June 30, 2020 | 24.03% |
| March 31, 2020 | -1.41% |
| December 31, 2019 | 28.16% |
| September 30, 2019 | 19.91% |
| June 30, 2019 | 16.21% |
| March 31, 2019 | 23.53% |
| December 31, 2018 | 25.55% |
| September 30, 2018 | -8.47% |
| June 30, 2018 | 46.51% |
| March 31, 2018 | 52.42% |
| September 30, 2017 | 38.38% |
| June 30, 2017 | 25.38% |
| March 31, 2017 | 29.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 55.48% |
| Bio-Rad Laboratories, Inc. | 53.12% |
| Bruker Corp. | 49.65% |
| Danaher Corp. | 57.64% |
| Harvard Bioscience, Inc. | 51.96% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.07% |
| Return on Assets | -47.15% |
| Return on Invested Capital | -56.22% |
| Profit Margin (Quarterly) | -90.85% |
| Operating Margin (Quarterly) | -88.34% |
| Return on Net Operating Assets | -86.47% |